Piper Sandler Downgrades Inari Medical (NASDAQ:NARI) to Neutral
Inari Medical (NASDAQ:NARI – Get Free Report) was downgraded by stock analysts at Piper Sandler from an “overweight” rating to a “neutral” rating in a note issued to investors on Thursday, MarketBeat Ratings reports. They presently have a $55.00 target price on the stock, down from their prior target price of $85.00. Piper Sandler’s target […]